Certara, Inc. - Common Stock (NQ:CERT)

9.360 +0.020 (+0.21%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Expert Ratings for Certara ↗

March 27, 2023

Via Benzinga

Are These 3 Small Momentum Stocks Setting Up Big Gains?

March 22, 2023

MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.

Via MarketBeat

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Where Certara Stands With Analysts ↗

March 02, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 20, 2022

Thursday saw 177 companies set new 52-week lows.

Via Benzinga

Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday ↗

March 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

A.I. Coming to Certara’s D360 Scientific Informatics Software

March 09, 2023

New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.

From Certara

Via GlobeNewswire

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

March 07, 2023

Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies

From Certara

Via GlobeNewswire

Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday ↗

March 02, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Certara Reports Fourth Quarter and Full Year 2022 Financial Results

March 01, 2023

Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency

From Certara

Via GlobeNewswire

Certara Announces Transition Plan for Chief Financial Officer

March 01, 2023

From Certara

Via GlobeNewswire

Certara to Participate in the Barclays Global Healthcare Conference

February 27, 2023

From Certara

Via GlobeNewswire

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023

February 01, 2023

From Certara

Via GlobeNewswire

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

January 04, 2023

Certara improves software capabilities by expanding into deep learning and data fabric

From Certara

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

December 08, 2022

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity

From Certara

Via GlobeNewswire

Why Certara's Shares Rose 37.7% This Week ↗

November 11, 2022

The company, which helps other companies in their drug development, reported strong third-quarter numbers.

Via The Motley Fool

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday ↗

November 08, 2022

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Certara Reports Third Quarter 2022 Financial Results

November 07, 2022

Biosimulation software and services fuel third quarter growth

From Certara

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Dow Up Triple Digits Ahead Of Busy Week ↗

November 07, 2022

The Dow Jones Industrial Average is up 212 points midday, continuing Friday's flourish, while the Nasdaq Composite and S&P 500 Index sit more hesitantly in the black.

Via Talk Markets

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase

November 07, 2022

Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares

From Certara

Via GlobeNewswire

Earnings Outlook For Certara ↗

November 04, 2022

Certara (NASDAQ:CERT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Certara will report...

Via Benzinga

Certara to Participate in Upcoming Investor Conferences

November 02, 2022

From Certara

Via GlobeNewswire

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions

October 19, 2022

The PMDA enters 9th consecutive year of using Certara’s software

From Certara

Via GlobeNewswire

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022

October 13, 2022

From Certara

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.